Trial
NCT05321251
Topical Insulin Drops for the Treatment of Neurotrophic Keratopathy.
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Alberta
Collaborators
—
Condition
Neurotrophic Keratitis
Intervention
Insulin
Why stopped
Study never commenced due to logistical issues.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-02-05